For research use only. Not for therapeutic Use.
FPL-13210 is a disopyramide derivative.
| Catalog Number | I027738 |
| CAS Number | 143305-97-9 |
| Synonyms | FPL-13210; FPL 13210; FPL13210 |
| Molecular Formula | C22H29BrN2O2 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | (S)-2-((R)-(2-bromophenyl)(hydroxy)methyl)-5-(dimethylamino)-N,N-dimethyl-2-phenylpentanamide |
| InChI | InChI=1S/C22H29BrN2O2/c1-24(2)16-10-15-22(21(27)25(3)4,17-11-6-5-7-12-17)20(26)18-13-8-9-14-19(18)23/h5-9,11-14,20,26H,10,15-16H2,1-4H3/t20-,22-/m0/s1 |
| InChIKey | JVKFYSJJNSJAEZ-UNMCSNQZSA-N |
| SMILES | CN(C)CCC[C@]([C@@H](O)c1ccccc1Br)(C(=O)N(C)C)c2ccccc2 |
| Reference | 1. Knilans TK, Varró A, Nánási PP, Murray RJ, Kaiser FC, Lathrop DA. Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramide. Cardiovasc Drugs Ther. 1991 Feb;5(1):139-46. doi: 10.1007/BF03029809. PMID: 2036332. |
